Bacterial infections often produce pain and inflammation. In normal practice, two groups of agents (chemotherapeutic, analgesic and anti-inflammatory) are prescribed simultaneously. The compounds possessing all three activities are not common. Quinazolines and condensed quinazolines exhibit potent antimicrobial 1) and CNS activities like analgesic, 2) anti-inflammatory 3) and anticonvulsant 4) activities. In view of these facts and to develop our earlier reported 2-phenyl-3-substituted quinazolines, 5) 2,3-disubstituted quinazolines 6) and 2-methyl-3-substituted quinazolin-4-(3H)-ones 7) that exhibited good analgesic and anti-inflammatory activities, in the present study we aimed to synthesize some 2-methylthio-3-substituted quinazolin-4(3H)-ones. The title compounds were synthesized by nucleophilic substitution of (2-methylthio-4-oxo-3H-quinazolin-3-yl)dithiocarbamic acid methyl ester with different amines. The (2-methylthio-4-oxo-3H-quinazolin-3-yl)dithiocarbamic acid methyl ester was synthesized by reacting the amino group of 3-amino-2-methylthioquinazoline with carbondisulphide and dimethyl sulphate. The 3-amino-2-methylthio quinazoline was synthesized from anthranilic acid (Chart 1). Spectral data (IR, NMR, and mass spectra) confirmed the structures of the synthesized compounds, the purity of these compounds was ascertained by microanalysis (Table 1 ). The synthesized compounds were tested for their analgesic, anti-inflammatory and antibacterial activities.
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CHEMISTRY
Melting points were determined in open capillary tubes on a Thomas Hoover apparatus and are uncorrected. IR spectra were recorded in KBr on a Perkin Elmer-841 grating spectrometer (cm Ϫ1 ), mass spectra on a varian Atlas CH-7 mass spectrometer at 70 eV and NMR spectra on a varian A-60 or EM-360 spectrometer, using tetramethylsilane as internal standard. Elemental analysis were performed on Carlo erba 1108.
Synthesis of 3-Amino-2-mercaptoquinazolin-4(3H)-one To a vigorously stirred solution of methylanthranilate 3.02 g (0.02 mol) in dimethylsulfoxide (10 ml) at room temperature, carbondisulphide (1.6 ml, 0.026 mol) and aqueous sodium hydroxide 1.2 ml (20 mol solution) was added dropwise simultaneously during 30 min and it was stirred for 30 min more. Dimethyl sulphate 2.5 g (0.02 mol) was added dropwise under cooling with an ice bath. Stirring was continued for 3 h, the reaction mixture was poured into ice-water and then it was extracted with chloroform. The solvent was removed by distillation under reduced pressure. Thus the obtained crude methyl N-(2-methoxycarbonylphenyl)dithiocarbamate was used for further reaction without purification.
Hydrazine hydrate 8.6 g (0.2 mol) was added dropwise to a stirred methyl N- (2- 
Synthesis of (2-Methylthio-4-oxo-3H-quinazolin-3-yl)-dithiocarbamic acid methyl ester
To a vigorously stirred solution of 3-amino-2-methylthioquinazolin-4(3H)-one 3.86 g (0.02 mol) in dimethyl sulfoxide (10 ml) at room temperature carbondisulphide (1.6 ml, 0.026 mol) and sodium hydroxide (1.2 ml, 20 mol solution) were added dropwise during 30 min, it was allowed to stirr for 30 min more. Dimethyl sulphate 2.5 g (0.02 mol) was added at 5-10°C, stirring was continued for 3 h and the reaction mixture was poured into ice water, the solid, so obtained was filtered, washed with water, dried and recrystallized from ethanol, yieldϭ73%, mp 95-97°C, IR (KBr) cm 
Synthesis of 1-Methyl-3-(2-methlylthio-4-oxo-3H-quinazolin-3-yl)thiourea (A1)
A mixture of (2-methylthio-4-oxo-3H-quinazolin-3-yl)dithiocarbamic acid methyl ester 3.27 g (0.01 mol) and methylamine 0.62 g (0.02 mol) in N,Ndimethyl formamide (20 ml) was refluxed for 20 h cooled and poured into ice water, the solid obtained was filtered, dried and recrystallized from ethanol, yieldϭ71%, mp 166-169°C, IR (KBr) cm 
PHARMACOLOGY
The synthesized compounds were evaluated for analgesic, anti-inflammatory and antimicrobial activities. Student-t-test was performed for all the activities to ascertain the significance of the exhibited activities. The test compounds and the standard drugs were administered in the form of a suspension (1% carboxyl methyl cellulose as vehicle) in the same route of administration. Each group consisted of six animals.
Animals The animals were procured from "National Biological Center," Madurai, India, and were maintained in colony cages at 25Ϯ2°C, relative humidity of 45-55%, maintained under 12 h light and dark cycle and were fed with standard animal feed. All the animals were acclimatized for a week before use.
Analgesic Activity 8, 9) Test for analgesic activity was performed by tail-flick technique using Wistar albino mice (25-35 g) of either sex selected by random sampling technique Diclofenac sodium at a dose level of 10 and 20 mg/kg was administered orally as reference drug for comparison. The test compounds at two dose levels (10, 20 mg/kg) were administered orally. The reaction time was recorded at 30 min, 1, 2 and 3 h after the treatment. The cut off time was 10 s. The percent analgesic activity (PAA) was calculated by the following formula, Where T 1 is the reaction time (s) before treatment, T 2 is the reaction time (s) after treatment.
Anti-inflammatory Activity Anti-inflammatory activity was performed by carrageenan-induced paw oedema test in 10) Diclofenac sodium 10, 20 mg/kg was administered as standard drug for comparison. The test compounds were administered at two dose levels (10 mg, 20 mg/kg). The paw volumes were measured using the mercury displacement technique with the help of a plethysmograph immediately before and 30 min, 1, 2 and 3 h after carrageenan injection. The percent inhibition of paw oedema was calculated by using the following formula
Where x is the mean paw volume of rats before the administration of carrageenan and test compounds or reference compound (test group), a is the mean paw volume of rats after the administration of carrageenan in the test group (drug treated), b is the mean paw volume of rats after the administration of carrageenan in the control group, y is the mean paw volume of rats before the administration of carrageenan in the control group.
Antibacterial Activity Evaluation of antibacterial activity by agar dilution method.
11) The standard strains were procured from the American Type Culture Collection (ATCC), Rockville, U.S.A., and the pathological strains were procured from the Department of Microbiology, Madurai Medical College and Research Institute, Madurai, India. The antibacterial activity of the synthesized compounds were screened against the following bacterial strains: Proteus vulgaris ATCC 9484, Salmonella typhimurium ATCC 33068, Klebsiella pneumoniae ATCC 13883, Edwardsiella tarda, Pseudomonas aeruginosa ATCC 2853, Bacillus subtilis ATCC 6051, Salmonella paratyphi, all bacteria were grown on Muller-Hinton Agar (Hi-media) plates (37°C, 24 h) then the minimum inhibitory concentration (MIC) was considered to be the lowest concentration that completely inhibited the growth on agar plates, disregarding a single colony or faint haze caused by the inoculums. The MIC of the test compounds were compared with the reference drug norfloxacin.
RESULTS AND DISCUSSION
The results of analgesic activity indicate that all the test compounds exhibited significant activity ( Table 2 ). The compound A1 with methyl substitution showed good activity, with the increased lipophilicity (dimethyl group) compound A2 shown increase in activity. Further increase in lipophilicity (diethyl group) A3 led to further increase in activity. Substitution with alicyclic amines A4 retains the activity. Placement of alicyclic amines with additional heteroatoms A5, A6 led to decrease in activity. Aromatic substitution A7 to A11 shown still lower activity. The compounds with aliphatic substitution (A1-A4) shown the better activity. The compound A3 was found to be the most active analgesic agent and it is more potent than diclofenac sodium and our earlier reported 2,3-disubstituted quinazolin-4(3H)-ones.
The anti-inflammatory activity data (Table 3) indicated that all the test compound protected rats from carrageenaninduced inflammation and are more potent than our earlier reported 2,3-disubstituted quinazolin-4(3H)-ones. The compound A4 showed more anti-inflammatory activity than that 654 Vol. 27, No. 5 
